FDA warning letters issued to four major research peptide vendors over unapproved drug marketing.
For Licensed Prescribers
After the shutdowns, where compliant clinics actually source.
In 2025, three of the largest gray-market peptide vendors went dark. Compounding restrictions tightened. Then, the regulatory winds shifted. This is the supply chain physicians are rebuilding with.
The Last 18 Months
A timeline of supply chain disruption.
Major gray-market vendor raided by federal authorities. Domestic shipping infrastructure disrupted.
HHS announces ~14 of 19 peptides moving back to Category 1, restoring legal compounding access.
The largest gray-market supplier voluntarily shuts down. Thousands of clinics lose their primary source overnight.
Federal Register publication expected. Demand from prescribers surges. Compliant supply chains scale up.
The supply layer for the next decade.
Cascadia Labs was built around what physicians needed when the dust settled: a verified, lab-tested, physician-only marketplace.
Verified Suppliers
FDA-aligned sources only. Brutally scrutinized before listing.
Lab Tested
USPP-certified multi-panel testing on every vial.
Gated Access
License-verified physicians only. No consumer access.
Rebuild your supply chain right.
Free physician verification. Wholesale pricing after credentials clear.
Verify Your License